Trends and Risk Factors for Venous Thromboembolism Among Hospitalized Medical Patients
Elad Neeman(Kaiser Permanente San Rafael Medical Center), Raymond Liu(Kaiser Permanente), Pranita Mishra(Kaiser Permanente), James Xu(Kaiser Permanente), Heather Clancy(Kaiser Permanente), David Schlessinger(Kaiser Permanente), Vincent Liu(University of Iowa Hospitals and Clinics), Khanh K. Thai(Kaiser Permanente)
Cited by 113
Related Papers
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis
|Gastroenterology|2020|1.7k
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
|The Lancet|2020|1.6k
Hyperimmune IV Immunoglobulin Treatment
|CHEST Journal|2013|293
Increased 1-Year Healthcare Use in Survivors of Severe Sepsis
|American Journal of Respiratory and Critical Care Medicine|2014|276